Koninklijke Philips | PHG - Cash And Equivalent


Koninklijke Philips reported EUR1.91B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Boston Scientific USD 1.45B 512M Mar/2026
Danaher USD 5.7B 1.09B Mar/2026
Demant DKK 1.33B 188M Dec/2025
Dexcom USD 1.12B 200.5M Mar/2026
Edwards Lifesciences USD 2.4B 538M Mar/2026
Fresenius EUR 1.31B 81M Dec/2025
General Electric Aerospace USD 10.98B 1.41B Mar/2026
Getinge SEK 2.96B 720M Dec/2024
Globus Medical USD 560.95M 34.79M Mar/2026
GN Store Nord DKK 1.12B 352M Dec/2025
Hitachi JPY 1.28T 412.69B Sep/2025
Idexx Laboratories USD 200.53M 20.46M Mar/2026
Insulet USD 480.4M 235.7M Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
Intuitive Surgical USD 7.98B 1.05B Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Koninklijke Philips EUR 1.91B 90M Sep/2025
Masimo USD 124.6M 187.7M Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Philips EUR 2.79B 882M Dec/2025
ResMed USD 1.66B 243.44M Mar/2026
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 2.88B 1.13B Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Terumo JPY 217.16B 12.86B Sep/2025
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026